Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a note issued to investors on Sunday. The firm set a “hold” rating on the stock.

Aspira Women’s Health Stock Performance

Shares of AWH opened at $0.63 on Friday. The firm has a market capitalization of $10.51 million, a price-to-earnings ratio of -0.53 and a beta of 1.42. Aspira Women’s Health has a one year low of $0.60 and a one year high of $5.65. The stock’s fifty day moving average is $0.77 and its 200-day moving average is $0.95.

Hedge Funds Weigh In On Aspira Women’s Health

An institutional investor recently raised its position in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. boosted its holdings in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 316,294 shares of the company’s stock after acquiring an additional 79,898 shares during the quarter. B. Riley Wealth Advisors Inc. owned 1.90% of Aspira Women’s Health worth $256,000 at the end of the most recent quarter. 12.19% of the stock is currently owned by hedge funds and other institutional investors.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.